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ABSTRACT
Background Pigmented skin lesions or ‘moles’
are a common presenting problem in general prac-
tice consultations: while the majority are benign,
a minority are malignant melanomas. The
MoleMateTM system is a novel diagnostic toolwhich
incorporates spectrophotometric intracutaneous ana-
lysis (SIAscopy) within a non-invasive scanning
technique and utilises a diagnostic algorithm spe-
ciﬁcally developed for use in primary care. The
MoleMateTM training program is a short, com-
puter-based course developed to train primary
care practitioners to operate theMoleMateTM diag-
nostic tool.
Objectives This pre-trial study used mixed
methods to assess the eﬀectiveness and acceptability
of a computer-based training program CD-ROM,
developed to teach primary care practitioners to
identify the seven features of suspicious pigmented
lesions (SPLs) seen with the MoleMateTM system.
Method Twenty-ﬁve practitioners worked through
the MoleMateTM training program: data on feature
recognition and time taken to conduct the assess-
ment of each lesion were collected. Acceptability of
the training program and the MoleMateTM system
in general was assessed by questionnaire.
Results The MoleMateTM training program im-
proved users’ feature recognition by 10% (pre-test
median 73.8%, p<0.001), and reduced the time
taken to complete assessment of 30 SPLs (pre-test
median 21 minutes 53 seconds, median improve-
ment 3 minutes 17 seconds, p<0.001). All prac-
titioners’ feature recognition improved (21/21),
with most also improving their time (18/21). Prac-
titioners rated the training program as eﬀective and
easy to use.
Conclusion The MoleMateTM training program is
a potentially eﬀective and acceptable informatics
tool to teach practitioners to recognise the features
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Introduction
In the UK malignant melanoma is the eighth most
common cancer, with 8100 new cases and 1800 deaths
annually;1 the incidence has doubled over the last 20
years.2 Patients often present to their general prac-
titioners (GPs) with concerns about pigmented skin
lesions, but GPs rarely see malignant melanomas. The
earlier a melanoma is detected and the ‘thinner’ the
lesion, the better the prognosis.3 Therefore the man-
agement of suspicious pigmented skin lesions, and in
particular the recognition of potential malignant
melanomas, is an essential skill in general practice.
GPs are less accurate than dermatologists in the
diagnosis of skin cancers,4,5 and there is conﬂicting,6,7
and probably insuﬃcient,8 evidence about the conﬁ-
dence and ability of GPs to manage pigmented skin
lesions. GPs are able to improve their diagnostic and
management skills in dermatology through a variety
of training methods,9 sometimes to the level of spe-
cialists.10 However, training may not improve man-
agement decisions in the longer term,11 and current
practice has been shown to inﬂuence diagnostic ability
more than previous dermatology training.12
Primary care practitioners are currently able to use a
variety of checklists to assist their management of
pigmented skin lesions, including the seven-point
checklist (as recommended in the NICE skin cancer
guidelines)13,14 and the ‘ABCD(E)’ checklist (as recom-
mended in the SIGN guidelines).15,16 These checklists
are sensitive for the diagnosis ofmalignantmelanoma,
but are low on speciﬁcity.17 Technology such as derm-
oscopy, photography and teledermatology may also
assist pigmented skin lesion management decisions.
Although there is a consensus on the use of derm-
oscopy in secondary care,18 there is less evidence that
using the dermatoscope in primary care increases the
accuracy of diagnosis.19 Photographs may be useful in
the referral and follow-up of patients with pigmented
skin lesions.20 Teledermatology has been assessed in
secondary care for the remote diagnosis of pigmented
skin lesions,21 and has recently been successfully piloted
in a primary care setting.22
Despite the wide availability of guidelines and
newer technologies to aid the management of pig-
mented skin lesions in primary care, only 10–12% of
referrals made under the UK ‘two-week wait’ skin
cancer referral criteria are malignant.23 This places
dermatology departments under considerable press-
ure, highlighting the need for increased speciﬁcity for
the diagnosis of pigmented skin lesions, combined
with the continued need for high sensitivity in order
not to miss an early malignant melanoma diagnosis.
The MoleMateTM system is a novel diagnostic tool
for the management of pigmented skin lesions by
primary care practitioners. The system uses SIAscopy,
a technology that examines the haemoglobin, melanin
and collagen levels in the epidermis and dermis. There
is increasing evidence to show that SIAscopy improves
accuracy of diagnosis in secondary care,24 although a
recent study with equivocal results used an outdated
version of the technology.25,26 As the prevalence of
pigmented skin lesions in the general population is
very diﬀerent from that in secondary care, a diagnostic
algorithm has been speciﬁcally developed and veriﬁed
for use in primary care (Figure 1).27 TheMoleMateTM
system consists of a hand-held scanner which trans-
mits images (SIAscans) to computer software incorp-
orating the algorithm. The primary care practitioner
looks for the presence or absence of certain features on
the computer screen images and, by following the
algorithm, ascertains whether the lesion is suspicious
and needs further investigation. A CD-ROM has been
developed in order to train primary care practitioners
to identify the features seen with the MoleMateTM
system. The aim of this study was to evaluate the
eﬀectiveness and acceptability of the MoleMateTM
training program among primary care practitioners.
Method
The MoleMateTM system as a
diagnostic tool
Adermatoscopic image of the pigmented skin lesion is
viewed ﬁrst, followed by the SIAscan images in the
order of the MoleMateTM algorithm (bright dots,
melanin brain, blood lacunes, dermal melanin, blood
vessels and blood displacement). Finally, the lesion is
measured using an on-screen measuring tool. The
of SPLs identiﬁed by the MoleMateTM system. It
will be used as part of the intervention in a
randomised controlled trial to compare the diag-
nostic accuracy and appropriate referral rates of
practitioners using the MoleMateTM system with
best practice in primary care.
Keywords: computer-aided diagnosis, primary
care, suspicious pigmented lesion.
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3Figure 1 The MoleMateTM system algorithm with SIAscan images
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primary care practitioner must indicate whether or
not each feature is present, and whether the lesion
is greater or less than 6 mm in diameter. By following
the algorithm, the practitioner is able to identifywhether
a lesion is benign (such as a seborrhoeic keratosis or
haemangioma), or whether the lesion is suspicious
and needs further investigation.
The MoleMateTM training program
CD-ROM
The training program consists of four sections:
1 Demonstration Introduction and illustration of
features seen with the MoleMateTM system, using
SIAscans of 13 pigmented skin lesions.
2 Pre-test Baseline assessment of SIAscans of 30
pigmented skin lesions.
3 Feedback Review of pre-test responses with mis-
takes highlighted and examples of the SIAscan
features given. Practitioners must review every
incorrect answer.
4 Post-test Assessment of SIAscans of a further set of
30 pigmented skin lesions, including nine from the
pre-test set and 21 new lesions.
The practitioner’s assessments of the SIAscan images
for each lesion, plus the time taken to assess each
lesion, are recorded automatically as a binary variable
by the software and are ‘scored’ against the ‘gold
standard’ assessment of whether each feature is pres-
ent or absent (reached by consensus between scientists
and clinicians involved in the development of the
MoleMateTM system).
The ‘pre-test/post-test design’ has been widely used
across many disciplines to evaluate and quantify learn-
ing, especially of change over a short period of time. It
has previously been used to assess interventions to
increase GPs’ knowledge of malignant melanoma and
skin cancer and to assess computer-aided instruction
for other clinical situations such as cardio-pulmonary
resuscitation and surgery.9,11,28,29
Development of the MoleMateTM
training program
The MoleMateTM training program was developed
by Astron Clinica in collaboration with primary care
researchers. Images were selected to reﬂect the case
mix generally observed inUKprimary care, from cases
which were relatively straightforward to assess. Initial
piloting by four primary care practitioners and three
scientists led to small modiﬁcations to the program.
These included making minor alterations to nomen-
clature and abbreviations throughout, clarifying the
features seen in the demonstration section by adding
arrows and increasing the annotation and highlighting
of features in the feedback section. A short break was
introduced into the training session after the pre-test
section to reduce fatigue.
Pigmented skin lesion workshops
Primary care practitioners were recruited by ﬂyer and
email to attend one of two Pigmented Skin Lesion
workshops held duringMarch and April 2007. At each
workshop the participants completed the MoleMateTM
training program, then a consultant plastic surgeon
(PH) talked about the management and referral of
pigmented skin lesions. Participants were given 90
minutes to work through the training program, which
included a refreshment break. These workshops were
held in the evening and vouchers to cover travel costs
were provided.
Analysis
Eﬀectiveness of the MoleMateTM training
program
Diﬀerences between the average pre- and post-test
scores and times taken to conduct each assessment
were summarised using the median and the inter-
quartile range, as the data had outliers and were
therefore not consistent with a normal distribution.
The start time and the time at which each questionwas
completedwere recorded by the program, but the time
at the end of the last question was not recorded: the
time taken to complete the last question was approx-
imated by using the mean for the previous nine
questions.
Data were analysed in SPSS (12.0.1), using non-
parametric statistical methods, and any p value <0.05
was regarded as statistically signiﬁcant. The pre- and
post-test datawere comparedusing aWilcoxonmatched
pairs signed rank sum test. Diﬀerences between the
pre- and post-test data for groups of practitioners
(GPs, GPRegistrars (GPRs), practice nurses (PNs) and a
physician’s assistant (PA)) were compared using a
Mann Whitney U test with exact test option. As there
were less than ﬁve practitioners in the PN/PA group,
the results were summarised but not analysed further
due to the impossibility of declaring statistical signiﬁ-
cance. Pre- and post-test scores for each feature seen
with the MoleMateTM system were compared using
a Wilcoxon matched pairs signed rank sum test to
identify any change in participants’ ability to correctly
identify each feature. Pre-test scores and times for
participants who did not complete the training program
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were compared to those who did using the Mann
Whitney U test with exact test option.
Acceptability of the MoleMateTM training
program
Participants were asked for their views on the
MoleMateTM training program using a speciﬁcally
designed questionnaire. This included a series of
statements with which participants were asked to rate
their agreement or disagreement on a 7-point Likert
scale, with ‘1’ being strongly agree, ‘7’ being strongly
disagree and ‘4’ being neutral. The questionnaire asked
practitioners to rate the ease of identifying each of the
features seen with the MoleMateTM system. Descriptive
statistics were used to analyse the questionnaire re-
sponses and comparisons were made between diﬀerent
groups of practitioners. Also, the views of any partici-
pants who did not complete the training program
were compared to the views of those who did (see
Appendix 1, the questionnaire).
Results
Twenty-ﬁve primary care practitioners attended two
Pigmented Skin Lesion workshops, with 21 completing
the MoleMateTM training program. The program com-
pleter group consisted of eight GPs (average age 41
(range 34–60); 50% female; average of 17 (range 9–30)
years’ general practice experience) and ten GPRs
(average age 31 (range 26–40); 70% female; average
of 0.75 (range 0.5–1) years’ general practice experience).
There were also two PNs and one PA in general practice
who were considered as one group in the summary
analysis but formed too small a cohort for further
group analysis (average age 45 (range 30–56); 100%
female; average of 18 (range 17–19) years’ general
practice experience). Four GPs failed to complete the
program due to time pressure (average age 49 (range
46–55); 50% female; average of 18 (range 9–26) years’
general practice experience).
Eﬀectiveness of the MoleMateTM
training program
Feature recognition
The median pre-test score was 73.8% (inter-quartile
range (IQR) 67.9%–78.3%), the median post-test
score was 86.2% (IQR 81.0%–88.3%) and all partici-
pants improved after completing the feedback session.
There was a highly signiﬁcant improvement between
median pre- and post-test scores (10.0%, IQR 7.6%–
15.0%, p<0.001). All three groups of primary care
practitioners had higher scores in the post-test than
the pre-test. The improvement was signiﬁcant for GPs
and GPRs (median improvement 10.4%, p=0.012 and
11.6%, p=0.005, respectively) and was in the same
direction for the small PN/PA group (median 15.7%),
see Figure 2.
Diﬀerences between pre- and post-test scores were
evaluated for each of the individual features seen with
the MoleMateTM system: more participants correctly
identiﬁed each feature in the post-test. The most
signiﬁcant improvement was in the identiﬁcation of
blood lacunes (median=25%, p<0.001) and blood
displacement (median=20%, p<0.001), see Figure 3.
Diﬀerences between scores for lesions in both pre-
and post-test sets (n=9) were compared with pre- and
post-test scores for the unique lesions (n=21). For the
Figure 2 Comparing median pre- and post-test scores between GPs (n=8), GPRs (n=10) and PN/PAs (n=3)
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unique lesions, the median pre-test score was 74.8%
(IQR 67.3%–80.0%) and the median post-test score
was 85.7% (IQR 82.0%–89.1%), giving a median
improvement in accuracy of 8.8% (IQR 6.5%–11.7%,
p<0.001). For the repeated lesions, themedian pre-test
score was 69.8% (IQR 64.3%–76.2%) and the median
post-test score was 84.1% (IQR 80.2%–87.3%), giving
a median improvement in accuracy of 11.1% (IQR
9.5%–17.5%, p<0.001).
Time taken to complete the MoleMateTM
training program
Themedian time taken to complete the pre-test was 21
minutes and 53 seconds (21:53), (IQR 17:41–26:41)
and the post-test was 17:51 (IQR 15:45–20:04). Eight-
een participants completed the post-test more quickly
than the pre-test: three participants were slower (by
7 seconds, 22 seconds and 2 minutes, respectively).
The participants who were quicker were signiﬁcantly
faster at completing the post-test than the pre-test
(median 3:17, IQR 1:16–7:09, p<0.001). All three
groups of practitioners were quicker on average at
completing the post-test than the pre-test: for both
GPs and GPRs this diﬀerence was signiﬁcant (p=0.017
and p=0.028, respectively) but not for the PN/PA
group (p=0.109), see Figure 4.
Participants who did not complete the
MoleMateTM training program
The pre-test scores and times of the four non-
completers were compared to those of participants
who did complete the training program. The median
pre-test score for non-completers was 61.2% (51.4%,
56.7%, 65.7%, 71.0%), signiﬁcantly lower than the
pre-test scores of participants who did complete the
training program (p=0.029). The median time taken
for non-completers to ﬁnish the pre-test was 27:37
seconds (20:54, 21:42, 33:33, 35:29), not signiﬁcantly
Figure 3 Comparing pre- and post-test scores for individual features of lesions (n=21)
Figure 4 Comparing median pre- and post-test times between GPs (n=8), GPRs (n=10) and PN/PAs (n=3)
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longer than participants who did complete the train-
ing program (p=0.231).
Practitioners’ views on the
MoleMateTM Training Program
The majority of participants found the MoleMateTM
training program easy to use (86%, n=21). Most agreed
that it was easy to understand the demonstration
(81%, n=19) and that the feedback session was useful
(90%, n=22). Participants were asked about the ease
of identifying each individual feature seen with the
MoleMateTM system. The median Likert scale answer
was compared with the total score for each individual
feature. This reveals a negative association, demon-
strating that features scoring highly were easier to
identify (see Figure 5).
Despite these views, only half of the participants felt
conﬁdent in their management of a patient with a
suspicious pigmented skin lesion after the session
(overall 52%, n=11; GPs 62%, n=5; GPRs 60%, n=6;
PN/PAs 0%, n=0). The remainder were ‘unsure’
(overall 29%, n=6; GPs 25%, n=2; GPRs 20%, n=2;
PN/PAs 67%, n=2) or ‘not conﬁdent’ (overall 19%,
n=4; GPs 12%, n=1; GPRs 20%, n=2; and PN/PAs
33%, n=1).
Discussion
This study has shown that the MoleMateTM training
program is a potentially eﬀective tool for teaching
primary care practitioners to recognise the features of
pigmented skin lesions seen with the MoleMateTM
system. Comparing pre- and post-education scores,
there was an overall improvement in feature recognition
and time taken, with a signiﬁcant improvement among
the GPs and GPRs. The MoleMateTM training program
was developed through collaboration between industry
and academia and iterative steps were taken during
the piloting phase to improve the educational content
and ease of use. This was reﬂected in the participants’
very positive views about the MoleMateTM training
program.
The improvements in feature recognition were seen
for both the repeated lesions and the unique lesions,
suggesting that the learning of features could be gen-
eralised to new lesions. The study showed a signiﬁcant
improvement in participant recognition of some fea-
tures (blood lacunes, blood displacement, bright dots
and blood vessels). Recognition of the remaining
features showed less improvement, but the pre-test
accuracy level for these was much higher (melanin
brain 79%, dermal melanin 92%, diameter of lesion
85%) suggesting a ceiling eﬀect. In support of this,
when completing the questionnaire, the participants
were able to correctly identify which features were
more diﬃcult to recognise and accurately score. Similar
improvements in diagnostic decisions about possible
skin malignancies were found in a recent study using
dermoscopy after a short educational intervention.30
The four non-completers were all GPs. Their pri-
mary care and postgraduate dermatology experience
was similar to that of the GPs who did complete the
training program, but on average they were older.
They all completed the pre-test, and although their
median score was signiﬁcantly lower than those who
did complete theMoleMateTM training program, they
did not take signiﬁcantly longer. Despite not com-
pleting the post-test due to time restrictions, the
non-completers had similar views to the other par-
ticipants on the eﬀectiveness and acceptability of the
MoleMateTM training program.
The small number of participants limits the general-
isability of the ﬁndings from this study. Furthermore,
Figure 5 Comparing median post-test scores and median Likert Scale answers for each individual feature
seen with MoleMateTM
AWood, H Morris, J Emery et al48
there may have been selection bias due to the fact that,
although the Pigmented Skin Lesion workshops were
advertised to all GP practices in Hertfordshire and
Bedfordshire, the response was small and we therefore
extended the invitation to the local GP vocational
training scheme members. Attending practitioners
may therefore have had a greater interest in skin cancer
or an above-average interest in dermatology. They
were also more likely to be early adopters, although
only two practitioners indicated prior exposure to the
MoleMateTM system.
Despite the small number of participants, the study
is well powered because the training program design
includes 30 lesions for each test, with seven features
per lesion. The GP registrars may be more familiar with
informatics and computer-aided diagnostic programs,
although there were no signiﬁcant diﬀerences between
GPs andGPRs in feature recognition and time taken to
complete the training program. There were only two
practice nurses and one physician’s assistant among
the participants, making a very small group for com-
parison with with the GPs and GPRs. Finally, this pre-
test/post-test design only evaluates practitioners’ im-
mediate recall of the learning intervention, and we
need further evaluations of practitioner performance
over time, from randomised settings and after use in
the clinical situation.
We recognise that this pre-trial evaluation of the
MoleMateTM training program is theoretical and, as
such, the results have no immediate clinical value. It
will now be used as part of the intervention in a
randomised controlled trial to evaluate the eﬀective-
ness of using the MoleMateTM system compared with
normal best practice in UK primary care consultations.
The trial will report on the ability of practitioners to
evaluate individual pigmented skin lesions to deter-
mine whether the lesion is benign or suspicious and if
further specialist opinion is required.
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Appendix 1: Questionnaire
Use of the MoleMateTM Training Program*
1.1 It is easy to understand the demonstration
1.2 It is easy to see the bright dots on the collagen view
1.3 It is easy to see the melanin brain on the melanin view
1.4 It is easy to see the blood lacunes on the blood view
1.5 It is easy to see the bright colours on the dermal melanin view
1.6 It is easy to see the blood vessels on the blood view
1.7 It is easy to see the blood displacement with erythematous blush on the blood view
1.8 It is easy to measure the diameter of the lesion
1.9 The feedback session was useful
1.10 It is easy to use the MoleMateTM training program
Information about you
3.1 Name
3.2 Year of birth
3.3 Gender Male/Female
3.4 Years as a GP or Practice Nurse
3.5 Have you ever had any dermatological training? If yes, please describe
3.6 Have you ever seen MoleMateTM before?
3.7 Have you any further comments that would help us with the further development of the MoleMateTM
training program?
* 1.1–1.10 all assessed using a 7-point Likert scale, 1 = strongly agree, 4 = neither agree nor disagree, 7 = strongly disagree.
